Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Weight: early-phase trial registry

1 of 6 indexed Weight trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 1 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Weight: 6 US clinical trials tracked, 1 recruiting.

Weight is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Neothetics, running 1 of these trials.

Enrollment posture brief

Registry condition weight

OPEN 1 | RECR 17% | LATE 0 | EARLY 1 | RANK #2866 | SPON 1

Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Weight (this)17%
Open-enrollment share among volume-matched conditions near Weight

Weight lists 1 open slots (17% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Weight on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Weight is recruiting below its size-band peers.

    1 of 6 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Weight research.

    Neothetics accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Weight enrolment sits around 100 participants.

    Median target enrolment is 100 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.

  4. Weight research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Weight records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Dihydrocapsiate Other
1 trials
Sleep & calorie restriction Behavioral
1 trials
Calorie restriction only Behavioral
1 trials
Diet and exercise Behavioral
1 trials
LIPO-102, Placebo Drug
1 trials
LIPO-102 Low Drug
1 trials
LIPO-102 Drug
1 trials
Weight Bias Internalization Behavioral
1 trials

US sites by state

Facility locations filed on Weight trials. A trial with sites in several states counts in each.

South Carolina 1 trials
Rhode Island 1 trials
Pennsylvania 1 trials
New York 1 trials
Maryland 1 trials
Louisiana 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Weight page

6 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Weight condition card totals 6 registered trials; most-linked intervention Dihydrocapsiate; top US site state South Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.